Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00585286

Fractional Resurfacing Device for Treatment of Acne Scarring

Evaluation of a Novel Fractional Resurfacing Device for the Treatment of Acne Scarring

Sponsor: Reliant Technologies, Inc. Mountain View, CA

Interventions 10,600 nm fractional carbon dioxide laser system

Updated 8 times since 2017 Last updated: Dec 13, 2013 Started: Mar 31, 2007 Primary completion: Jul 31, 2008 Completion: Jul 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Acne and Scar, this trial is completed. The trial is conducted by Reliant Technologies, Inc. Mountain View, CA and has accumulated 8 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Dec 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Dec 2021 [monthly]

Completed PHASE1_PHASE2
Nov 2019 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 3 earlier versions

Jun 2018 — Nov 2019 [monthly]

Completed PHASE1_PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1_PHASE2

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Reliant Technologies, Inc. Mountain View, CA
University of California, Irvine
University of Minnesota

Data source: University of California, Irvine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Irvine, United States